DEUTSCHE BANK AG\ - INMUNE BIO INC ownership

INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 33 filers reported holding INMUNE BIO INC in Q1 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of INMUNE BIO INC
ValueSharesWeighting
Q3 2023$743,671
-32.3%
109,848
-9.3%
0.00%
-100.0%
Q2 2023$1,099,116
+40.6%
121,0480.0%0.00%
Q1 2023$781,970
+1.9%
121,0480.0%0.00%
Q4 2022$767,444
+2.3%
121,0480.0%0.00%
Q3 2022$750,000
-29.9%
121,0480.0%0.00%
-100.0%
Q2 2022$1,070,000
+19.8%
121,048
+14.1%
0.00%
Q1 2022$893,000
-17.5%
106,0480.0%0.00%
Q4 2021$1,082,000
-47.5%
106,048
-0.0%
0.00%
-100.0%
Q3 2021$2,059,000
+10.5%
106,056
+0.0%
0.00%0.0%
Q2 2021$1,863,000
+47.9%
106,0480.0%0.00%0.0%
Q1 2021$1,260,000
-23.8%
106,048
+10.4%
0.00%0.0%
Q4 2020$1,654,000
+67.1%
96,0480.0%0.00%0.0%
Q3 2020$990,000
+96.4%
96,0480.0%0.00%
Q2 2020$504,000
+169.5%
96,048
+71.4%
0.00%
Q1 2020$187,000
-30.0%
56,048
+21.7%
0.00%
Q4 2019$267,000
+9.9%
46,048
+11.4%
0.00%
Q3 2019$243,000
-25.0%
41,333
+24.0%
0.00%
Q2 2019$324,000
+24.1%
33,3330.0%0.00%
Q1 2019$261,00033,3330.00%
Other shareholders
INMUNE BIO INC shareholders Q1 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 275,000$5,341,0002.77%
Fermata Advisors, LLC 12,830$249,0000.11%
DG Capital Management, LLC 20,000$388,0000.08%
YorkBridge Wealth Partners, LLC 10,369$201,0000.05%
Ikarian Capital, LLC 26,632$517,0000.04%
Financial Advocates Investment Management 16,667$324,0000.02%
Janney Montgomery Scott LLC 99,323$1,929,0000.01%
Belvedere Trading LLC 16,177$302,0000.01%
FNY Investment Advisers, LLC 800$15,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 17,200$334,0000.01%
View complete list of INMUNE BIO INC shareholders